Announcements Trials
Browse Landscape

Phase

Phase 2 9Phase NA 8Phase 1 7Phase 3 4Phase 1/2 4Phase 2/3 3Phase EARLY_PHASE1 1

Status

Unknown 3Withdrawn 1Not yet recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 108Thoracic 37Breast 37Other hematologic neoplasm 33Lymphoid 21Genitourinary 18Head & Neck 13Tumor-Agnostic 12Gynecologic 12CNS 10Plasma cell 7Myeloid 7Sarcoma 6Dermatologic 4Other neoplasm 3Endocrine 3Other solid neoplasm 2Other 2Classical hematology 2

Conditions

TP53 1Primary Malignant Neoplasm of Ovary 1Allogeneic Hematopoietic Stem Cell Transplantation 1

Interventions

Decitabine 3Cyclophosphamide 2Busulfan 2Paclitaxel 1Carboplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 2/3 × Unknown × Other neoplasm × Clear all
NCT04123392 2019-10-10

Decitabine + BUCY vs BUCY Conditioning Regimen for TP53+ Myeloid Tumors Undergoing Allo-HSCT

Nanfang Hospital, Southern Medical University

Phase 2/3 Unknown
196 enrolled
Other neoplasm

TP53

NCT04098653 2019-09-23

Decitabine + BUCY vs BUCY Conditioning Regimen for Myeloid Tumors Undergoing Allo-HSCT

Nanfang Hospital, Southern Medical University

Phase 2/3 Unknown
196 enrolled
Other neoplasm

Allogeneic Hematopoietic Stem Cell Transplantation

NCT02159820 2014-06-10

DAC and CT

Chinese PLA General Hospital

Phase 2/3 Unknown
500 enrolled
Other neoplasm

Primary Malignant Neoplasm of Ovary

Data powered by HemOnc (CC BY 4.0) Colophon âš¡